With advances in surgical techniques, multidisciplinary care and immunosuppression, patient and graft survival continue to improve in liver transplantation (LT). Excellent patient and graft survival have translated into an aging liver transplant recipient (LTRs) cohort that resembles a general chronic disease population. (1) LTRs are becoming more medically complex related to LT indication (e.g. non‐alcoholic fatty liver disease) and with increased prevalence of relevant chronic conditions such as chronic kidney disease (CKD) (1, 2)

中文翻译：

---

肝移植和慢性病管理：超越患者和移植物的存活。

随着手术技术、多学科护理和免疫抑制的进步，肝移植 (LT) 患者和移植物的存活率不断提高。出色的患者和移植物存活率已转化为类似于一般慢性病人群的老龄化肝移植受者 (LTR) 队列。(1) LTR 在医学上变得越来越复杂，与 LT 适应症（例如非酒精性脂肪性肝病）相关，并且慢性肾病 (CKD) 等相关慢性疾病的患病率增加 (1, 2)